logo
One thing that could help prevent motor neurone disease and dementia

One thing that could help prevent motor neurone disease and dementia

Independent25-02-2025
New research suggests omega-3 fats could play a vital role in protecting people from motor neurone disease (MND) and a type of dementia.
While previous studies linked a high consumption of omega-3 fatty acids with a lower risk of developing MND and a longer lifespan for those with the condition, until now, researchers have not understood why this occurs.
A study led by the UK Dementia Research Institute and the UCL Institute of Healthy Ageing found the fats – which are found in oily fish, nuts and seeds – affect the conditions and may boost survival.
In the new research, experts increased the levels of healthy fats in the brain cells of fruit flies carrying a genetic mutation called C9orf72, while also examining human brain cells.
C9orf72 mutation is the most common genetic cause of MND and a rarer form of dementia known as frontotemporal dementia (FTD), which tends to affect younger people.
The team found that, at the start of the study, levels of poly-unsaturated fatty acids, including omega-3 fatty acids, were significantly reduced in the MND/FTD flies.
These fatty acids were also reduced in the brain cells of people with MND/FTD.
Experts specifically looked at alpha linoleic acid (ALA), a type of omega-3 fatty acid found in flaxseed, walnuts and soybean and vegetable oils such as canola oil.
They also looked at linoleic acid, a type of omega-6 fatty acid, found in similar foods.
Scientists fed the flies linoleic acid and alpha linoleic acid to test whether this would impact on their survival.
They found that increasing the amount of fatty acids in their diet led to a small improvement in the survival of the flies.
Next, they delivered the fatty acids directly to the brain cells of the flies which increased the survival of the flies by 83 per cent, from 15 days to 27.5 days.
They repeated the experiment in cells taken from people with MND/FTD and found that increasing levels of the fatty acids in the cells prolonged survival.
The research, published in the journal Nature Neuroscience, was funded by Alzheimer's Research UK and the UK Dementia Research Institute.
Study leader Professor Adrian Isaacs, from the UK Dementia Research Institute, said: 'Epidemiological studies suggest that people with a high intake of omega-3 fatty acids have a lower risk of developing motor neuron disease.
'Our study adds a deeper understanding of the mechanisms behind this.
'From our findings we can conclude that enhancing levels of omega-3 fatty acids in the brain may be beneficial in motor neuron disease. Of course, the next step is to test this in people.
'We first need to work out which specific fatty acid would be best to test in humans, and how we can deliver sufficient quantities to the brain. Then, we want to take these findings forward into a clinical trial.'
The researchers also suggested the findings may also have implications for other neurodegenerative diseases.
Dr Julia Dudley, head of research at Alzheimer's Research UK, said: 'With nearly one million people living with dementia in the UK, there is an urgent need to understand and treat the diseases that cause this condition, including rarer forms.
'Neurodegenerative diseases are complex, however some share similar genetic changes.
'This means that understanding how these changes affect the brain could ultimately lead to new treatment approaches for dementia.
'It is exciting to see findings which suggest that increasing levels of fatty acids, including omega-3 could be protective against motor neuron disease and frontotemporal dementia.
'We are excited to see the next steps for this research which we hope will play a key role in bringing us closer to a cure.'
Last year, MND campaigner and Leeds Rhinos, Great Britain and England rugby league star Rob Burrow died from MND.
His family said they were inundated with messages of support when he died, including a 'heartfelt' message from the Prince of Wales.
MND, including its most common subtype amyotrophic lateral sclerosis (ALS), affects around one in 300 people in their lifetime and cannot be cured.
Dr Nick Cole, head of research at the MND Association, said: 'The potential impact of healthy fats, like polyunsaturated fats such as omega-3s, on the risk of developing MND and the length of survival has been of interest to researchers for some time, but crucially the understanding of their impact has been limited. This research takes our knowledge on a step.
'So would giving people with MND the same type of fatty acid increase their survival rate?
'We don't know yet. But it is an avenue worth exploring. The researchers must now look at which fatty acids should be tested further, in what quantities they could be effective and how they should be administered, before they carry out a clinical trial.
'We hope that further research and testing in humans will paint a clearer picture on the impact of diet on MND and other neurodegenerative diseases.
'In the meantime, we would advise anyone with MND to speak to their healthcare professionals before making any changes to their diet.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Cats develop dementia similarly to humans
Cats develop dementia similarly to humans

Leader Live

time12 hours ago

  • Leader Live

Cats develop dementia similarly to humans

Experts at the University of Edinburgh carried out a post-mortem brain examination on 25 cats which exhibited symptoms of dementia in life, including confusion, sleep disruption and an increase in vocalisation, in a bid explore new treatments for humans. Previously, researchers have studied genetically modified rodents, although the species does not naturally suffer from dementia. In feline dementia brains, a build-up was found of amyloid-beta, a toxic protein and one of the defining features of Alzheimer's disease, leading to hopes of a 'wonderful' breakthrough due to increased accuracy. The breakthrough was hailed as a 'perfect natural model for Alzheimer's' by scientists who worked on it. Microscopy images revealed a build-up of amyloid-beta within synapses of older cats and feline dementia, and scientists hope the findings offer a clearer idea of how amyloid-beta may lead to feline cognitive dysfunction and memory loss, offering a valuable model for studying dementia in people. Synapses allow the flow of messages between brain cells, and losing these causes reduced memory and thinking abilities in humans with Alzheimer's. Researchers found evidence that brain support cells, astrocytes and microglia, engulfed the affected synapses, known as synaptic pruning, an important process during brain development but which contributes to dementia. Experts believe the findings could contribute to the development of new treatments for Alzheimer's disease, as well as help to understand and manage feline dementia. Previously, scientists studying Alzheimer's relied on genetically modified rodent models. However, studying feline dementia has the potential to help develop human treatments, due to increased accuracy, it is hoped. The study, funded by Wellcome and the UK Dementia Research Institute, is published in the European Journal of Neuroscience, and included scientists from the Universities of Edinburgh and California, UK Dementia Research Institute and Scottish Brain Sciences. Dr Robert McGeachan, study lead from the University of Edinburgh's Royal (Dick) School of Veterinary Studies, said: 'Dementia is a devastating disease – whether it affects humans, cats, or dogs. Our findings highlight the striking similarities between feline dementia and Alzheimer's disease in people. 'This opens the door to exploring whether promising new treatments for human Alzheimer's disease could also help our ageing pets. 'Because cats naturally develop these brain changes, they may also offer a more accurate model of the disease than traditional laboratory animals, ultimately benefiting both species and their caregivers.' Professor Danielle Gunn-Moore, personal chair of Feline Medicine at the Royal (Dick) School of Veterinary Studies, said: 'Feline dementia is so distressing for the cat and for its person. 'It is by undertaking studies like this that we will understand how best to treat them. This will be wonderful for the cats, their owners, people with Alzheimer's and their loved ones. 'Feline dementia is the perfect natural model for Alzheimer's – everyone benefits.'

Cats develop dementia similarly to humans
Cats develop dementia similarly to humans

Rhyl Journal

time14 hours ago

  • Rhyl Journal

Cats develop dementia similarly to humans

Experts at the University of Edinburgh carried out a post-mortem brain examination on 25 cats which exhibited symptoms of dementia in life, including confusion, sleep disruption and an increase in vocalisation, in a bid explore new treatments for humans. Previously, researchers have studied genetically modified rodents, although the species does not naturally suffer from dementia. In feline dementia brains, a build-up was found of amyloid-beta, a toxic protein and one of the defining features of Alzheimer's disease, leading to hopes of a 'wonderful' breakthrough due to increased accuracy. The breakthrough was hailed as a 'perfect natural model for Alzheimer's' by scientists who worked on it. Microscopy images revealed a build-up of amyloid-beta within synapses of older cats and feline dementia, and scientists hope the findings offer a clearer idea of how amyloid-beta may lead to feline cognitive dysfunction and memory loss, offering a valuable model for studying dementia in people. Synapses allow the flow of messages between brain cells, and losing these causes reduced memory and thinking abilities in humans with Alzheimer's. Researchers found evidence that brain support cells, astrocytes and microglia, engulfed the affected synapses, known as synaptic pruning, an important process during brain development but which contributes to dementia. Experts believe the findings could contribute to the development of new treatments for Alzheimer's disease, as well as help to understand and manage feline dementia. Previously, scientists studying Alzheimer's relied on genetically modified rodent models. However, studying feline dementia has the potential to help develop human treatments, due to increased accuracy, it is hoped. The study, funded by Wellcome and the UK Dementia Research Institute, is published in the European Journal of Neuroscience, and included scientists from the Universities of Edinburgh and California, UK Dementia Research Institute and Scottish Brain Sciences. Dr Robert McGeachan, study lead from the University of Edinburgh's Royal (Dick) School of Veterinary Studies, said: 'Dementia is a devastating disease – whether it affects humans, cats, or dogs. Our findings highlight the striking similarities between feline dementia and Alzheimer's disease in people. 'This opens the door to exploring whether promising new treatments for human Alzheimer's disease could also help our ageing pets. 'Because cats naturally develop these brain changes, they may also offer a more accurate model of the disease than traditional laboratory animals, ultimately benefiting both species and their caregivers.' Professor Danielle Gunn-Moore, personal chair of Feline Medicine at the Royal (Dick) School of Veterinary Studies, said: 'Feline dementia is so distressing for the cat and for its person. 'It is by undertaking studies like this that we will understand how best to treat them. This will be wonderful for the cats, their owners, people with Alzheimer's and their loved ones. 'Feline dementia is the perfect natural model for Alzheimer's – everyone benefits.'

Cats develop dementia similarly to humans
Cats develop dementia similarly to humans

South Wales Argus

time18 hours ago

  • South Wales Argus

Cats develop dementia similarly to humans

Experts at the University of Edinburgh carried out a post-mortem brain examination on 25 cats which exhibited symptoms of dementia in life, including confusion, sleep disruption and an increase in vocalisation, in a bid explore new treatments for humans. Previously, researchers have studied genetically modified rodents, although the species does not naturally suffer from dementia. In feline dementia brains, a build-up was found of amyloid-beta, a toxic protein and one of the defining features of Alzheimer's disease, leading to hopes of a 'wonderful' breakthrough due to increased accuracy. The breakthrough was hailed as a 'perfect natural model for Alzheimer's' by scientists who worked on it. Microscopy images revealed a build-up of amyloid-beta within synapses of older cats and feline dementia, and scientists hope the findings offer a clearer idea of how amyloid-beta may lead to feline cognitive dysfunction and memory loss, offering a valuable model for studying dementia in people. Synapses allow the flow of messages between brain cells, and losing these causes reduced memory and thinking abilities in humans with Alzheimer's. Researchers found evidence that brain support cells, astrocytes and microglia, engulfed the affected synapses, known as synaptic pruning, an important process during brain development but which contributes to dementia. Experts believe the findings could contribute to the development of new treatments for Alzheimer's disease, as well as help to understand and manage feline dementia. Previously, scientists studying Alzheimer's relied on genetically modified rodent models. However, studying feline dementia has the potential to help develop human treatments, due to increased accuracy, it is hoped. The study, funded by Wellcome and the UK Dementia Research Institute, is published in the European Journal of Neuroscience, and included scientists from the Universities of Edinburgh and California, UK Dementia Research Institute and Scottish Brain Sciences. Dr Robert McGeachan, study lead from the University of Edinburgh's Royal (Dick) School of Veterinary Studies, said: 'Dementia is a devastating disease – whether it affects humans, cats, or dogs. Our findings highlight the striking similarities between feline dementia and Alzheimer's disease in people. 'This opens the door to exploring whether promising new treatments for human Alzheimer's disease could also help our ageing pets. 'Because cats naturally develop these brain changes, they may also offer a more accurate model of the disease than traditional laboratory animals, ultimately benefiting both species and their caregivers.' Professor Danielle Gunn-Moore, personal chair of Feline Medicine at the Royal (Dick) School of Veterinary Studies, said: 'Feline dementia is so distressing for the cat and for its person. 'It is by undertaking studies like this that we will understand how best to treat them. This will be wonderful for the cats, their owners, people with Alzheimer's and their loved ones. 'Feline dementia is the perfect natural model for Alzheimer's – everyone benefits.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store